YLU-32377-84935
4 vaccinations
6 coded responses
17 check-ins
6 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 400 / KY
- Registered
- 2021-05-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-05
Dose 1 — Moderna
-
2021-05-05
Dose 2 — Moderna
-
2021-05-06
Registered in v-safe
-
2021-05-06
Survey response — days 1–6 daily, dose 2MedDRA: Musculoskeletal stiffness — Feeling: Poor · Site: Pain, Redness, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Stiff neckMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-07
Survey response — days 1–6 daily, dose 2MedDRA: Hyperhidrosis — Feeling: Fair · Site: Pain, Redness, Itching · Joint pains, Abdominal painFree text: Detox sweatsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-08
- 2021-05-09
- 2021-05-10
- 2021-05-11
- 2021-05-12
- 2021-05-19
- 2021-05-26
- 2021-06-02
-
2021-06-09
Survey response — day 35, dose 2MedDRA: Menstrual clots, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Large clots in menstruation · Healthcare visit (other): Schedule DNCMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-09
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-06-17
Survey response — day 42, dose 2MedDRA: Cyst — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cyst in earMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-17
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-06-21
Call successfulParticipant prefers to complete VAERS report online
-
2021-06-21
Call successfulParticipant prefers to complete VAERS report online
- 2021-08-06
-
2021-11-03
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: PregnantMedDRA releases: 2024-11 · check-in free text available
-
2021-12-02
Dose 3 — Moderna
- 2022-06-02
-
2022-10-02
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-12-02
Survey response — 12 months, dose 3MedDRA: Hypothyroidism, Melanocytic naevus, Seborrhoeic keratosis — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Barnacle and mole growths and hypothyroidismMedDRA releases: 2024-11 · check-in free text available
-
2022-12-02
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-05
- 2023-01-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-05 | Moderna | |
| 2 | 2021-05-05 | Moderna | |
| 3 | 2021-12-02 | Moderna | No |
| 4 | 2022-10-02 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-09 | Successful 2021-06-21 |
Participant prefers to complete VAERS report online |
| 2021-06-17 | Successful 2021-06-21 |
Participant prefers to complete VAERS report online |
| 2022-12-02 | Unsuccessful |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Stiff neck
Systemic reaction (other): Detox sweats
Release 9 — day 35, dose 2
Release 9 — day 42, dose 2
Symptoms: Cyst in ear
Release 10 — 6 months, dose 2
Symptoms: Pregnant
Release 12 — 12 months, dose 3
Symptoms: Barnacle and mole growths and hypothyroidism
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Cyst | ✓ | ✓ | ✓ |
| SD | Hypothyroidism | · | · | ✓ |
| SD | Melanocytic naevus | · | · | ✓ |
| SD | Menstrual clots | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Seborrhoeic keratosis | · | · | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Musculoskeletal stiffness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release